The phase 3 trial AMPLIFY study plans to test the diagnostic performance of 64Cu-SAR-bisPSMA PET/CT imaging in approximately ...
Patients with metastatic prostate cancer may have improved survival outcomes after undergoing next-generation PSMA PET ...
Ascension St. John is doing their part to make the fight against cancer as easy as possible. They were the first in the state ...
Siemens Healthineers, India’s recent partnership with HealthCare Global Enterprises (HCG), is aimed to revolutionize cancer ...
In this feature we spoke to Michael J. Morris, MD, and Benjamin Garmezy, MD, on the future of radioligand therapy in patients ...
The findings, published in The Lancet Oncology, might significantly minimize the number of unnecessary procedures and ensure ...
UCLA researchers developed a non-invasive imaging method using 89Zr-TLX250 to detect clear-cell renal cell carcinoma. This ...
California: A recent study conducted by UCLA Health Jonsson Comprehensive Cancer Center researchers found that new, non-invasive imaging technology can detect clear-cell renal cell carcinoma, the ...
Clarity Pharmaceuticals Dr Alan Taylor Catherine Strong Executive Chairman Investor/Media Relations ataylor@claritypharm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback